Abstract
The specificity of SCF ubiquitin ligase–mediated protein degradation is determined by F-box proteins1,2. We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCFCdc4. A co-crystal structure reveals that SCF-I2 inserts itself between the β-strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 Å away from the substrate binding site. Long-range transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Willems, A.R., Schwab, M. & Tyers, M. A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. Biophys. Acta 1695, 133–170 (2004).
Petroski, M.D. & Deshaies, R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9–20 (2005).
Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425–479 (1998).
Nalepa, G., Rolfe, M. & Harper, J.W. Drug discovery in the ubiquitin-proteasome system. Nat. Rev. Drug Discov. 5, 596–613 (2006).
Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263–274 (1996).
Verma, R. et al. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase. Science 278, 455–460 (1997).
Patton, E.E. et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev. 12, 692–705 (1998).
Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438–449 (2008).
Welcker, M. & Clurman, B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8, 83–93 (2008).
Yen, H.C. & Elledge, S.J. Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 322, 923–929 (2008).
Smith, T.F., Gaitatzes, C., Saxena, K. & Neer, E.J. The WD repeat: a common architecture for diverse functions. Trends Biochem. Sci. 24, 181–185 (1999).
Makarova, K.S., Wolf, Y.I., Mekhedov, S.L., Mirkin, B.G. & Koonin, E.V. Ancestral paralogs and pseudoparalogs and their role in the emergence of the eukaryotic cell. Nucleic Acids Res. 33, 4626–4638 (2005).
Fulop, V. & Jones, D.T. Beta propellers: structural rigidity and functional diversity. Curr. Opin. Struct. Biol. 9, 715–721 (1999).
Nash, P. et al. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514–521 (2001).
Rajagopalan, H. et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 428, 77–81 (2004).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Blanchard, J.E. et al. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem. Biol. 11, 1445–1453 (2004).
Brunel, J.M. BINOL: a versatile chiral reagent. Chem. Rev. 105, 857–897 (2005).
Barbey, R. et al. Inducible dissociation of SCF(Met30) ubiquitin ligase mediates a rapid transcriptional response to cadmium. EMBO J. 24, 521–532 (2005).
Orlicky, S., Tang, X., Willems, A., Tyers, M. & Sicheri, F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 112, 243–256 (2003).
Lagerstrom, M.C. & Schioth, H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339–357 (2008).
Loew, A., Ho, Y.K., Blundell, T. & Bax, B. Phosducin induces a structural change in transducin beta gamma. Structure 6, 1007–1019 (1998).
Vassilev, L.T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844–848 (2004).
Fulop, V., Bocskei, Z. & Polgar, L. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell 94, 161–170 (1998).
Juhasz, T., Szeltner, Z., Fulop, V. & Polgar, L. Unclosed beta-propellers display stable structures: implications for substrate access to the active site of prolyl oligopeptidase. J. Mol. Biol. 346, 907–917 (2005).
Suel, G.M., Lockless, S.W., Wall, M.A. & Ranganathan, R. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat. Struct. Biol. 10, 59–69 (2003).
May, L.T., Leach, K., Sexton, P.M. & Christopoulos, A. Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 47, 1–51 (2007).
Wullschleger, S., Loewith, R. & Hall, M.N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006).
Hao, B., Oehlmann, S., Sowa, M.E., Harper, J.W. & Pavletich, N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell 26, 131–143 (2007).
Tang, X. et al. Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination. Cell 129, 1165–1176 (2007).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905–921 (1998).
Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Kleywegt, G.J. Crystallographic refinement of ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 63, 94–100 (2007).
Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240–255 (1997).
Christie, K.R. et al. Saccharomyces Genome Database (SGD) provides tools to identify and analyze sequences from Saccharomyces cerevisiae and related sequences from other organisms. Nucleic Acids Res. 32, D311–D314 (2004).
Zdobnov, E.M. & Apweiler, R. InterProScan–an integration platform for the signaturerecognition methods in InterPro. Bioinformatics 17, 847–848 (2001).
UniProt Consortium The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res. 38, D142–D148 (2010).
Eddy, S.R., Mitchison, G. & Durbin, R. Maximum discrimination hidden Markov models of sequence consensus. J. Comput. Biol. 2, 9–23 (1995).
Do, C.B., Mahabhashyam, M.S., Brudno, M. & Batzoglou, S. ProbCons: Probabilistic consistency-based multiple sequence alignment. Genome Res. 15, 330–340 (2005).
Acknowledgements
We thank M. Auer, J. Walton and M. Bradley for stimulating discussions. This work was supported by grants to F.S. and M.T. from the Canadian Institutes of Health Research (MOP-57795), to E.D.B. from the Ontario Research and Development Challenge Fund and to M.T. from the National Cancer Institute of Canada and the European Research Council. F.S. is supported by a Canada Research Chair in Structural Biology of Signal Transduction and M.T. is supported by a Research Chair of the Scottish Universities Life Sciences Alliance and a Royal Society Wolfson Research Merit Award.
Author information
Authors and Affiliations
Contributions
S.O., small-molecule library screen, affinity determinations and structural analysis; X.T., in vitro substrate binding and ubiquitination assays; V.N., bioinformatic analysis and sequence alignments; N.E. and E.D.B., small-molecule library screen; F.S. and M.T. conceived and directed the project, interpreted results and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–3 and Supplementary Figs. 1–5 (PDF 931 kb)
Rights and permissions
About this article
Cite this article
Orlicky, S., Tang, X., Neduva, V. et al. An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase. Nat Biotechnol 28, 733–737 (2010). https://doi.org/10.1038/nbt.1646
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1646
This article is cited by
-
SCFβTrCP-mediated degradation of SHARP1 in triple-negative breast cancer
Cell Death & Disease (2023)
-
A robust yeast biocontainment system with two-layered regulation switch dependent on unnatural amino acid
Nature Communications (2023)
-
A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assay
Scientific Reports (2023)
-
The role of ubiquitination in tumorigenesis and targeted drug discovery
Signal Transduction and Targeted Therapy (2020)
-
WD40 repeat domain proteins: a novel target class?
Nature Reviews Drug Discovery (2017)